Can a Simple Antiviral Reduce Alzheimer's Risk?
Research suggests that the common cold sore virus, HSV-1, may play a role in triggering Alzheimer's disease by contributing to the buildup of amyloid-beta in the brain. A recent study found that people with HSV-1 had an 80% higher risk of developing Alzheimer's, but those who received antiviral treatment had a 17% lower risk. While the connection is still correlational and not definitive, these findings add a new perspective to the ongoing research on Alzheimer's disease.
The cold sore virus, herpes simplex virus type 1 (HSV-1), may play a role in triggering brain changes linked to Alzheimer’s disease. Studies suggest that HSV-1, which causes cold sores, can invade nerve cells in the brain and contribute to the buildup of amyloid-beta, a key feature of Alzheimer’s. Research shows that individuals with HSV-1 have a higher risk of developing Alzheimer’s, and antiviral treatment may lower this risk. However, the exact relationship between HSV-1 and Alzheimer’s is still being studied, and more research is needed to understand the connection.
Alzheimer’s disease is a complex condition influenced by factors such as age, genetics, lifestyle, and now, potentially chronic infections like HSV-1. While the exact cause of Alzheimer’s remains unclear, studies like these help researchers piece together the puzzle of this debilitating disease.
According to the source: The Times of India.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
